Assuntos
Receptor de Insulina/genética , Animais , Animais Recém-Nascidos , Sequência de Bases , Primers do DNA/química , Expressão Gênica , Genes Letais , Homozigoto , Camundongos , Camundongos Knockout , Dados de Sequência Molecular , Fosfoproteínas/metabolismo , Receptor de Insulina/metabolismo , Receptores de Somatomedina/metabolismoRESUMO
We have investigated the metabolic actions of recombinant human IGF-1 in mice genetically deficient of insulin receptors (IR-/-). After intraperitoneal administration, IGF-1 caused a prompt and sustained decrease of plasma glucose levels in IR-/- mice. Plasma free fatty acid concentrations were unaffected. Interestingly, the effects of IGF-1 were identical in normal mice (IR+/+) and in IR-/- mice. Despite decreased glucose levels, IR-/- mice treated with IGF-1 died within 2-3 d of birth, like sham-treated IR-/- controls. In skeletal muscle, IGF-1 treatment caused phosphorylation of IGF-1 receptors and increased the levels of the phosphatidylinositol-3-kinase p85 subunit detected in antiphosphotyrosine immunoprecipitates, consistent with the possibility that IGF-1 stimulates glucose uptake in a phosphatidylinositol-3-kinase-dependent manner. IGF-1 receptor phosphorylation and coimmunoprecipitation of phosphatidylinositol3-kinase by antiphosphotyrosine antibodies was also observed in liver, and was associated with a decrease in mRNA levels of the key gluconeogenetic enzyme phosphoenolpyruvate carboxykinase. Thus, the effect of IGF-1 on plasma glucose levels may be accounted for by increased peripheral glucose use and by inhibition of hepatic gluconeogenesis. These data indicate that IGF-1 can mimic insulin's effects on glucose metabolism by acting through its own receptor. The failure of IGF-1 to rescue the lethal phenotype due to lack of insulin receptors suggests that IGF-1 receptors cannot effectively mediate all the metabolic actions of insulin receptors.
Assuntos
Glicemia/metabolismo , Hipoglicemia/induzido quimicamente , Fator de Crescimento Insulin-Like I/farmacologia , Receptor IGF Tipo 1/metabolismo , Receptor de Insulina/deficiência , Animais , Animais Recém-Nascidos , Glicemia/efeitos dos fármacos , Transformação Celular Viral , Células Cultivadas , Éxons , Ácidos Graxos não Esterificados/sangue , Heterozigoto , Humanos , Injeções Intraperitoneais , Fator de Crescimento Insulin-Like I/administração & dosagem , Fígado/metabolismo , Camundongos , Camundongos Knockout , Músculo Esquelético/metabolismo , Fosforilação , Reação em Cadeia da Polimerase , Receptor IGF Tipo 1/biossíntese , Receptor de Insulina/biossíntese , Receptor de Insulina/genética , Proteínas Recombinantes/administração & dosagem , Proteínas Recombinantes/farmacologia , Vírus 40 dos SímiosRESUMO
While most effects of dopamine in the brain are mediated by the D1 and D2 receptor subtypes, other members of this G protein-coupled receptor family have potentially important functions. D3 receptors belong to the D2-like subclass of dopamine receptors, activation of which inhibits adenylyl cyclase. Using targeted mutagenesis in mouse embryonic stem cells, we have generated mice lacking functional D3 receptors. A premature chain-termination mutation was introduced in the D3 receptor gene after residue Arg-148 in the second intracellular loop of the predicted protein sequence. Binding of the dopamine antagonist [125I]iodosulpride to D3 receptors was absent in mice homozygous for the mutation and greatly reduced in heterozygous mice. Behavioral analysis of mutant mice showed that this mutation is associated with hyperactivity in an exploratory test. Homozygous mice lacking D3 receptors display increased locomotor activity and rearing behavior. Mice heterozygous for the D3 receptor mutation show similar, albeit less pronounced, behavioral alterations. Our findings indicate that D3 receptors play an inhibitory role in the control of certain behaviors.